new weight loss drug retatrutide Retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works

CTV National News: Canada approves first generic GLP 1 drug in G7 Struggling with stubborn fat? Meet Retatrutide the triple action peptide that's changing everything we knew about weight loss! Unlike Semaglutide or Tirzepatide, Retatrutide activates GLP 1 + GIP + Glucagon receptors for a Refer a friend + receive $75 off your next purchase when a new client lists your name on their paperwork at sign up, you'll receive a $75 referral reward! #medicalweightloss #ResetHealth #glp1 # GLP 1 Agonist based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects, Part 1 GLP 1 Energy and Metabolism Booster Capsules by Troomy Troomy Nootropics